Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Wearable technology for respiratory disease monitoring

Wearable technology for respiratory disease monitoring

Stories Apr 12, 2023 3 minutes

A near-infrared spectroscopy sensor could aid in tracking the vital signs of acute and recovering pneumonia and COVID-19 patients.

A wireless monitoring technique developed by Vancouver Coastal Health Research Institute researcher Dr. Babak Shadgan can help clinicians monitor vital signs and patient health following respiratory diseases, such as pneumonia and COVID-19. 

“Our technique can provide measures to help clinicians monitor how well a patient's respiratory system is functioning,” says Shadgan.

Dr. Babak Shadgan is the director of the ICORD Implantable Biosensing Laboratory, an assistant professor in the Department of Orthopaedics, an associate in the School of Biomedical Engineering and an associate in the Department of Pathology and Laboratory Medicine at the University of British Columbia.

Placed on the skin and wirelessly connected to a computer-based machine-learning algorithm that aids in data analysis, the wearable near-infrared spectroscopy (NIRS) sensor can help track patients’ road to recovery. 

The NIRS sensor affixed to a research study participant’s chest.

NIRS technology emits light invisible to the human eye. Sitting on the near-infrared spectrum, NIRS light has a wavelength of 650 to 1,000 nanometres. In comparison, visible light has a wavelength of 380 to 700 nanometres, with violet at the shorter end of the spectrum and red at the longer end.

Light wavelengths in the near-infrared spectrum can harmlessly and non-invasively penetrate through tissues to measure tissue oxygenation levels. It does so by detecting the colour intensity of hemoglobin — proteins found in blood cells. Hemoglobin molecules transport oxygen to tissues and vary in colour depending on their level of oxygen saturation. 

While the effectiveness of NIRS at detecting tissue oxygenation levels is well established, Shadgan’s study is the first to test the application of NIRS as a wireless, wearable sensor to monitor respiratory measures of breathing rate, rhythm and depth with tissue oxygenation. 

“There is presently limited available data on the effectiveness of NIRS as a screening, diagnostic and monitoring tool for respiratory function in patients with pneumonia, particularly from the COVID-19 virus, which can infect the lungs and cause inflammation; fluid or pus buildup; and breathing difficulties,” says Shadgan. 

Wireless and non-invasive health monitoring for pneumonia patients

For Shadgan’s study, the research team tracked the breathing and pulse of 21 healthy study participants using the NIRS sensor, which was affixed to participants’ chests. 

Participants were seated at a table with the NIRS sensor affixed to their chest, a blood oxygen saturation monitor attached to their left index finger and a respiratory training device in front of them.

Closely monitored by study team members, participants were guided through a series of breathing exercises. One exercise involved restricted breathing through the respiratory trainer for five minutes to simulate the shortness of breath that often occurs when someone is sick with viral pneumonia. Participants also engaged in rapid breathing for five minutes to simulate the acute stage of pneumonia, when a patient is unable to take a deep breath. 

Researchers found that the NIRS sensor was able to track respiration rate and magnitude with 87 per cent efficacy compared to researchers’ observations and readings from the other vital signs monitoring technologies used in the study.

“At the end of the study, we found that the NIRS sensor accurately detected when participants were affected by irregular respiration and when they were not, along with their tissue oxygenation levels.”

This information tells an important story about the functioning of a patient’s respiratory system and overall health. It may also reveal patterns that can be recorded and used to determine when a patient requires further medical attention, when they have fully recovered from a disease or if they have or are likely to have lingering health effects from a disease.

“A multi-modal biosensor utilizing NIRS could be highly beneficial to screening, diagnosing and monitoring infectious respiratory diseases in the acute and chronic phases.”

Shadgan is already working on additional research studies with an enhanced machine-learning algorithm for the NIRS sensor, as well as NIRS sensor applications beyond pneumonia. 
 

Researchers

Babak Shadgan

Related Articles

Home blood pressure monitoring to curb uncontrolled hypertension

Wrist-worn heart rate monitor readings are less accurate for people with darker skin tones

New healthy aging program to supercharge digital health for seniors

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

International Collaboration on Repair Discoveries

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy